Your browser doesn't support javascript.
loading
Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism.
Braig, Friederike; Kriegs, Malte; Voigtlaender, Minna; Habel, Beate; Grob, Tobias; Biskup, Karina; Blanchard, Veronique; Sack, Markus; Thalhammer, Anja; Ben Batalla, Isabel; Braren, Ingke; Laban, Simon; Danielczyk, Antje; Goletz, Steffen; Jakubowicz, Elzbieta; Märkl, Bruno; Trepel, Martin; Knecht, Rainald; Riecken, Kristoffer; Fehse, Boris; Loges, Sonja; Bokemeyer, Carsten; Binder, Mascha.
Afiliação
  • Braig F; Department of Oncology and Hematology, BMT with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kriegs M; Radiation Biology and Radiooncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Voigtlaender M; Department of Oncology and Hematology, BMT with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Habel B; Bioassays and Nonclinical Studies, GLYCOTOPE GmbH, Berlin, Germany.
  • Grob T; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Biskup K; Institute for Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité University Medical Center Berlin, Berlin, Germany.
  • Blanchard V; Institute for Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité University Medical Center Berlin, Berlin, Germany.
  • Sack M; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany.
  • Thalhammer A; Department of Physical Biochemistry, Potsdam University, Potsdam, Germany.
  • Ben Batalla I; Department of Oncology and Hematology, BMT with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Braren I; Institute for Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Laban S; HEXT Vector Facility/Institute for Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Danielczyk A; Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.
  • Goletz S; Bioassays and Nonclinical Studies, GLYCOTOPE GmbH, Berlin, Germany.
  • Jakubowicz E; Bioassays and Nonclinical Studies, GLYCOTOPE GmbH, Berlin, Germany.
  • Märkl B; Pathological Institute, Klinikum Augsburg, Augsburg, Germany.
  • Trepel M; Pathological Institute, Klinikum Augsburg, Augsburg, Germany.
  • Knecht R; Department of Oncology and Hematology, BMT with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Riecken K; Department of Oncology and Hematology, Klinikum Augsburg, Augsburg, Germany.
  • Fehse B; Department of Otorhinolaryngology, Head and Neck Cancer Center of the University Cancer Center Hamburg, University Medical Center Hamburg, Hamburg, Germany.
  • Loges S; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bokemeyer C; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Binder M; Department of Oncology and Hematology, BMT with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Cancer Res ; 77(5): 1188-1199, 2017 03 01.
Article em En | MEDLINE | ID: mdl-28031227
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Receptores ErbB / Cetuximab / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Receptores ErbB / Cetuximab / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article